KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 102 filers reported holding KRYSTAL BIOTECH INC in Q3 2020. The put-call ratio across all filers is 2.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $103,000 | -61.6% | 1,975 | -50.0% | 0.00% | – |
| Q2 2021 | $268,000 | -11.8% | 3,950 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $304,000 | -76.7% | 3,950 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,304,000 | +667.1% | 3,950 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $170,000 | +3.7% | 3,950 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $164,000 | +925.0% | 3,950 | +953.3% | 0.00% | – |
| Q1 2020 | $16,000 | -23.8% | 375 | 0.0% | 0.00% | – |
| Q4 2019 | $21,000 | -89.5% | 375 | -93.5% | 0.00% | -100.0% |
| Q3 2019 | $200,000 | +51.5% | 5,765 | +76.0% | 0.00% | 0.0% |
| Q2 2019 | $132,000 | +22.2% | 3,275 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $108,000 | +77.0% | 3,275 | +12.0% | 0.00% | 0.0% |
| Q4 2018 | $61,000 | +56.4% | 2,925 | +31.5% | 0.00% | – |
| Q3 2018 | $39,000 | +18.2% | 2,225 | 0.0% | 0.00% | – |
| Q2 2018 | $33,000 | +50.0% | 2,225 | 0.0% | 0.00% | – |
| Q1 2018 | $22,000 | +100.0% | 2,225 | +122.5% | 0.00% | – |
| Q4 2017 | $11,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 2,003,367 | $232,390,572 | 11.06% |
| Frazier Life Sciences Management, L.P. | 988,460 | $114,661,360 | 7.62% |
| S Squared Technology, LLC | 108,215 | $12,552,940 | 6.77% |
| Avoro Capital Advisors LLC | 2,565,555 | $297,604,380 | 4.64% |
| APIS CAPITAL ADVISORS, LLC | 24,000 | $2,784,000 | 3.61% |
| Nicholas Investment Partners, LP | 355,611 | $41,250,876 | 3.08% |
| Ghost Tree Capital, LLC | 80,000 | $9,280,000 | 3.05% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 71,531 | $8,297,596 | 2.52% |
| Affinity Asset Advisors, LLC | 57,500 | $6,670,000 | 1.88% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 46,092 | $5,344,828 | 1.80% |